KEAP1 and neoplasm: Seemingly contradictory, various previous studies on tumor cell lines (38, 39) or murine DCs (8, 12) showed that SFN enhanced the cellular antioxidant capacity by increasing KEAP1/NRF2/ARE-dependent expression of phase II antioxidant enzymes, e.g., HO-1.